2.23
price down icon1.76%   -0.04
after-market Dopo l'orario di chiusura: 2.20 -0.03 -1.35%
loading
Precedente Chiudi:
$2.27
Aprire:
$2.27
Volume 24 ore:
70,636
Relative Volume:
1.46
Capitalizzazione di mercato:
$74.75M
Reddito:
$6.21M
Utile/perdita netta:
$-19.92M
Rapporto P/E:
-2.1238
EPS:
-1.05
Flusso di cassa netto:
$-16.76M
1 W Prestazione:
-9.90%
1M Prestazione:
-12.89%
6M Prestazione:
-15.21%
1 anno Prestazione:
-8.61%
Intervallo 1D:
Value
$2.17
$2.275
Intervallo di 1 settimana:
Value
$1.99
$2.3342
Portata 52W:
Value
$1.99
$3.798

InspireMD Inc. Stock (NSPR) Company Profile

Name
Nome
InspireMD Inc.
Name
Telefono
972 3 6917691
Name
Indirizzo
4 Menorat Hamaor Street, Tel Aviv
Name
Dipendente
36
Name
Cinguettio
@InspireMD
Name
Prossima data di guadagno
2025-03-12
Name
Ultimi documenti SEC
Name
NSPR's Discussions on Twitter

Confronta NSPR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
NSPR
InspireMD Inc.
2.23 74.75M 6.21M -19.92M -16.76M -1.05
Medical Devices icon
ABT
Abbott Laboratories
136.26 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
104.78 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
396.74 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
88.75 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.18 44.46B 5.54B 4.18B 623.10M 7.00

InspireMD Inc. Stock (NSPR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2016-01-07 Iniziato Rodman & Renshaw Buy
2015-03-13 Downgrade Oppenheimer Outperform → Perform
2013-11-26 Iniziato Oppenheimer Outperform

InspireMD Inc. Borsa (NSPR) Ultime notizie

pulisher
Jun 16, 2025

InspireMD’s embolic prevention system gains CE Mark approval - Yahoo Finance

Jun 16, 2025
pulisher
Jun 13, 2025

InspireMD receives CE mark approval for CGuard Prime stent system By Investing.com - Investing.com South Africa

Jun 13, 2025
pulisher
Jun 13, 2025

InspireMD Gains CE Mark for Stroke Device CGuard Prime - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

InspireMD Gains CE Mark Approval for CGuard® Prime - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

InspireMD announces CE Mark approval for CGuard Prime EPS - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke - The Manila Times

Jun 13, 2025
pulisher
Jun 13, 2025

InspireMD, Inc. Secures CE Mark Approval for CGuard® Prime EPS Carotid Stent System - Nasdaq

Jun 13, 2025
pulisher
Jun 13, 2025

InspireMD Announces CE Mark Approval for CGuard® Prime - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke - GlobeNewswire Inc.

Jun 13, 2025
pulisher
Jun 07, 2025

Millennium Management LLC Has $867,000 Position in InspireMD, Inc. (NYSE:NSPR) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Medical device company appoints CFO - The Business Journals

Jun 05, 2025
pulisher
Jun 04, 2025

InspireMD appoints Michael Lawless CFO - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Acquires 24,452 Shares of InspireMD, Inc. (NYSE:NSPR) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

InspireMD names Michael Lawless as new CFO By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

InspireMD Appoints Michael Lawless as CFO - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

InspireMD (NSPR) Announces New CFO Appointment | NSPR Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

InspireMD names Michael Lawless as new CFO - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

InspireMD Holds Annual Stockholders Meeting and Elections - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

InspireMD CFO Craig Shore to depart, Michael Lawless to succeed - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

InspireMD Appoints New CFO Amidst Strategic Expansion - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

InspireMD Announces Appointment Of Michael Lawless As Chief Financial Officer - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

InspireMD Taps Healthcare Veteran Michael Lawless as CFO Ahead of Major US Launch - Stock Titan

Jun 03, 2025
pulisher
May 23, 2025

Inspire Medical Systems (NYSE:INSP) and InspireMD (NYSE:NSPR) Head-To-Head Contrast - Defense World

May 23, 2025
pulisher
May 18, 2025

OrthoPediatrics (NASDAQ:KIDS) versus InspireMD (NYSE:NSPR) Critical Review - Defense World

May 18, 2025
pulisher
May 14, 2025

Piper Sandler Lowers InspireMD (NYSE:NSPR) Price Target to $4.00 - Defense World

May 14, 2025
pulisher
May 14, 2025

InspireMD Inc. Reports Q1 2025 Financial Results - MSN

May 14, 2025
pulisher
May 13, 2025

InspireMD outlines Q3 2025 FDA approval target for CGuard Prime - MSN

May 13, 2025
pulisher
May 12, 2025

InspireMD Inc’s Earnings Call: Growth Amid Challenges - MSN

May 12, 2025
pulisher
May 12, 2025

InspireMD (NSPR) Sees Price Target Reduction by Piper Sandler | - GuruFocus

May 12, 2025
pulisher
May 12, 2025

InspireMD price target lowered to $4 from $4.50 at Piper Sandler - TipRanks

May 12, 2025
pulisher
May 12, 2025

Piper Sandler cuts InspireMD stock price target to $4.00 By Investing.com - Investing.com South Africa

May 12, 2025
pulisher
May 12, 2025

Piper Sandler cuts InspireMD stock price target to $4.00 - Investing.com Australia

May 12, 2025
pulisher
May 12, 2025

InspireMD (NSPR) Price Target Reduced, FDA Approval Timeline Adj - GuruFocus

May 12, 2025
pulisher
May 11, 2025

InspireMD initiated with a Buy at Lake Street - TipRanks

May 11, 2025
pulisher
May 10, 2025

InspireMD, Inc. (NASDAQ:NSPR) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 10, 2025

InspireMD Inc (NSPR) Q1 2025 Earnings Report Preview: What To Lo - GuruFocus

May 10, 2025
pulisher
May 10, 2025

InspireMD Inc (NSPR) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges By GuruFocus - Investing.com Canada

May 10, 2025
pulisher
May 10, 2025

Earnings call transcript: InspireMD Q1 2025 shows mixed results - Investing.com

May 10, 2025
pulisher
May 09, 2025

InspireMD earnings beat by $0.09, revenue fell short of estimates - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

InspireMD reports Q1 EPS (22c) vs (21c) last year - TipRanks

May 09, 2025
pulisher
May 09, 2025

InspireMD (NSPR) Posts Slight Increase in Q1 Revenue | NSPR Stoc - GuruFocus

May 09, 2025
pulisher
May 09, 2025

InspireMD Inc (NSPR) Q1 2025 Earnings: Revenue of $1.53M Beats E - GuruFocus

May 09, 2025
pulisher
May 09, 2025

InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic - NewsBreak: Local News & Alerts

May 09, 2025
pulisher
May 09, 2025

InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic By Stocktwits - Investing.com India

May 09, 2025
pulisher
May 09, 2025

InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

InspireMD Reports First Quarter 2025 Financial Results - The Manila Times

May 09, 2025
pulisher
May 09, 2025

InspireMD, Inc. Reports Q1 2025 Financial Results and Anticipates FDA Approval for CGuard™ Prime Carotid Stent System - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Renaissance Technologies LLC Invests $27,000 in InspireMD, Inc. (NYSE:NSPR) - Defense World

May 09, 2025
pulisher
May 07, 2025

INSPIREMD Earnings Preview: Recent $NSPR Insider Trading, Hedge Fund Activity, and More - Nasdaq

May 07, 2025
pulisher
May 05, 2025

InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - Defense World

May 05, 2025

InspireMD Inc. Azioni (NSPR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$299.99
price down icon 4.52%
medical_devices PHG
$24.20
price up icon 0.92%
medical_devices STE
$242.66
price up icon 1.02%
$83.58
price down icon 4.25%
$75.95
price up icon 2.54%
medical_devices EW
$77.18
price down icon 1.32%
Capitalizzazione:     |  Volume (24 ore):